Harmony Biosciences Holdings (HRMY) Non Operating Income (2020 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Non Operating Income came in at -$127000.0 in Q1 2026, up 53.99% year-on-year from -$82475.3 in Q1 2025, and down 20.95% quarter-over-quarter from -$105000.0 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Non Operating Income (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Non Operating Income across 7 years of filings, most recently posting -$127000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$127000.0, up 53.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$531000.0 (down 161.58% YoY), and the FY2025 annual result was -$680000.0, down 900.0% from the prior year.
- Non Operating Income came in at -$127000.0 for Q1 2026 at Harmony Biosciences Holdings, down from -$105000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $193000.0 in Q4 2023 to a low of -$276000.0 in Q1 2025.
- The 5-year median for Non Operating Income is -$5000.0 (2023), against an average of -$32176.5.
- Across the five-year window, Non Operating Income jumped 950.0% in 2022 and slumped 7150.0% in 2024, its largest moves.
- Harmony Biosciences Holdings' Non Operating Income stood at $73000.0 in 2022, then jumped by 164.38% to $193000.0 in 2023, then retreated by 17.1% to $160000.0 in 2024, then slumped by 165.62% to -$105000.0 in 2025, then dropped by 20.95% to -$127000.0 in 2026.
- The last three Non Operating Income figures came in at -$127000.0 (Q1 2026), -$105000.0 (Q4 2025), and -$106000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | -193,000.00 |
| Mar 31, 2025 | -276,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -124,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | -141,000.00 |
| Dec 31, 2023 | 193,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -31,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | -20,000.00 |